Viral hepatitis in the elderly

Andres F. Carrion, Paul Martin

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

As life expectancy continues to rise, elderly adults represent a rapidly growing proportion of the population. The likelihood of complications of acute and chronic liver disease and overall mortality are higher in elderly populations. Several physiological changes associated with aging, greater prevalence of co-morbid conditions, and cumulative exposure to hepatotropic viruses and environmental hepatotoxins may contribute to worse outcomes of viral hepatitis in the elderly. Although pharmacotherapy for hepatitis B and C continues to evolve, the efficacy, tolerability, and side effects of these agents have not been studied extensively in elderly adults. Immunization against hepatitis A and B in naïve elderly adults is an important public health intervention that needs to be revised and broadened.

Original languageEnglish
Pages (from-to)691-697
Number of pages7
JournalAmerican Journal of Gastroenterology
Volume107
Issue number5
DOIs
StatePublished - May 1 2012

Fingerprint

Hepatitis
Hepatitis B
Hepatitis A
Hepatitis C
Life Expectancy
Population
Liver Diseases
Immunization
Chronic Disease
Public Health
Viruses
Drug Therapy
Mortality

ASJC Scopus subject areas

  • Gastroenterology
  • Medicine(all)

Cite this

Viral hepatitis in the elderly. / Carrion, Andres F.; Martin, Paul.

In: American Journal of Gastroenterology, Vol. 107, No. 5, 01.05.2012, p. 691-697.

Research output: Contribution to journalArticle

Carrion, Andres F. ; Martin, Paul. / Viral hepatitis in the elderly. In: American Journal of Gastroenterology. 2012 ; Vol. 107, No. 5. pp. 691-697.
@article{aea60974089f4f4f9b906ca83d956d13,
title = "Viral hepatitis in the elderly",
abstract = "As life expectancy continues to rise, elderly adults represent a rapidly growing proportion of the population. The likelihood of complications of acute and chronic liver disease and overall mortality are higher in elderly populations. Several physiological changes associated with aging, greater prevalence of co-morbid conditions, and cumulative exposure to hepatotropic viruses and environmental hepatotoxins may contribute to worse outcomes of viral hepatitis in the elderly. Although pharmacotherapy for hepatitis B and C continues to evolve, the efficacy, tolerability, and side effects of these agents have not been studied extensively in elderly adults. Immunization against hepatitis A and B in na{\"i}ve elderly adults is an important public health intervention that needs to be revised and broadened.",
author = "Carrion, {Andres F.} and Paul Martin",
year = "2012",
month = "5",
day = "1",
doi = "10.1038/ajg.2012.7",
language = "English",
volume = "107",
pages = "691--697",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Viral hepatitis in the elderly

AU - Carrion, Andres F.

AU - Martin, Paul

PY - 2012/5/1

Y1 - 2012/5/1

N2 - As life expectancy continues to rise, elderly adults represent a rapidly growing proportion of the population. The likelihood of complications of acute and chronic liver disease and overall mortality are higher in elderly populations. Several physiological changes associated with aging, greater prevalence of co-morbid conditions, and cumulative exposure to hepatotropic viruses and environmental hepatotoxins may contribute to worse outcomes of viral hepatitis in the elderly. Although pharmacotherapy for hepatitis B and C continues to evolve, the efficacy, tolerability, and side effects of these agents have not been studied extensively in elderly adults. Immunization against hepatitis A and B in naïve elderly adults is an important public health intervention that needs to be revised and broadened.

AB - As life expectancy continues to rise, elderly adults represent a rapidly growing proportion of the population. The likelihood of complications of acute and chronic liver disease and overall mortality are higher in elderly populations. Several physiological changes associated with aging, greater prevalence of co-morbid conditions, and cumulative exposure to hepatotropic viruses and environmental hepatotoxins may contribute to worse outcomes of viral hepatitis in the elderly. Although pharmacotherapy for hepatitis B and C continues to evolve, the efficacy, tolerability, and side effects of these agents have not been studied extensively in elderly adults. Immunization against hepatitis A and B in naïve elderly adults is an important public health intervention that needs to be revised and broadened.

UR - http://www.scopus.com/inward/record.url?scp=84862310758&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862310758&partnerID=8YFLogxK

U2 - 10.1038/ajg.2012.7

DO - 10.1038/ajg.2012.7

M3 - Article

C2 - 22290404

AN - SCOPUS:84862310758

VL - 107

SP - 691

EP - 697

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 5

ER -